Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-02

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating SHR0302 for non-radiographic axial spondyloarthritis; status and results not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SHR0302 (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Non-radiographic Axial Spondyloarthritis | Phase 3 | Status: UNKNOWN